Chemopreventive effect of S-allylcysteine and its relationship to the detoxification enzyme glutathione S-transferase

Sulfur-containing substances derived from garlic and onion have been shown to prevent experimental carcinogenesis. One of the hypotheses explaining the mechanisms of the chemopreventive activity of these substances is that they activate detoxification systems such as glutathione S-trans-ferase (GST)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Carcinogenesis (New York) 1996-05, Vol.17 (5), p.1041-1044
Hauptverfasser: Hatono, Shunso, Jimenez, Arnie, Wargovich, Michael J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1044
container_issue 5
container_start_page 1041
container_title Carcinogenesis (New York)
container_volume 17
creator Hatono, Shunso
Jimenez, Arnie
Wargovich, Michael J.
description Sulfur-containing substances derived from garlic and onion have been shown to prevent experimental carcinogenesis. One of the hypotheses explaining the mechanisms of the chemopreventive activity of these substances is that they activate detoxification systems such as glutathione S-trans-ferase (GST). In this study the effects of S-allylcysteine (SAC), a water-soluble organosulfur compound derived from garlic, on GST activities in the liver, small intestine and colon were investigated. Additionally, we examined SAC for chemopreventive effects on aberrant crypt foci, which are the most likely precursors of colon cancers. In the rat colonic aberrant crypt assay administration of SAC during the initiation period decreased the number of aberrant crypt foci by 33 and 54% in groups given 40 or 80% maximum tolerated dose (MTD) of SAC respectively. The number of aberrant crypt foci, however, was not changed when SAC was given during the promotion period. GST activity in the liver was increased significantly by 41% 12 h after a single oral administration of 3.5 mmol/kg SAC and this elevated GST level was maintained over a 72 h period. GST levels were increased significantly by the administration of SAC (1.8 mmol/kg/ day for 3 days) not only in the liver but also in the proximal and middle small bowel. Isozyme levels of GST after administration of SAC were also determined using Western blotting. Hepatic GST-α and GST-μ were significantly increased by 35 and 42% respectively after oral administration of SAC. GST-π levels were lower than the detection limit (130 ng/mg/protein) in both the control and SAC-treated groups. These results strongly support the previous working hypothesis that SAC exhibits chemopreventive activity by exerting specific effects on carcinogen detoxification systems.
doi_str_mv 10.1093/carcin/17.5.1041
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_15631854</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15631854</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-45a8a65844bc5394d2b0202294c37365d327be07916c1c92c1748cec51e4f2903</originalsourceid><addsrcrecordid>eNo9kM1v1DAQxS1EVZaWOxckHxC3tJ7YzscRbSlFqkRVKCAulncyZg1OsthO1eWvJ-2u9jTSe2_eaH6MvQZxBqKV52gj-uEc6jM9CwqesQWoShQlNOI5WwhQspBSqhfsZUq_hYBK6vaYHTeVEi2IBZuWa-rHTaR7GrK_J07OEWY-Ov6lsCFsA25TJj8Qt0PHfU48UrDZj0Na-w3PI89r4h3l8cE7j08Op-Hftif-K0zZ5vWs0NyWox2So2gTnbIjZ0OiV_t5wu4uP3xdXhXXnz9-Wr6_LlBJlQulbWMr3Si1Qi1b1ZUrUYqybBXKWla6k2W9IlG3UCFgWyLUqkFCDaRc2Qp5wt7tejdx_DtRyqb3CSkEO9A4JQO6ktBoNQfFLohxTCmSM5voexu3BoR5JG12pA3URptH0vPKm333tOqpOyzs0c7-271vE9rg5u_Rp0NMikbJp8vFLuZnzA8H28Y_pqplrc3Vj5_mBi6-fV_eXpob-R8CvJiW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15631854</pqid></control><display><type>article</type><title>Chemopreventive effect of S-allylcysteine and its relationship to the detoxification enzyme glutathione S-transferase</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Hatono, Shunso ; Jimenez, Arnie ; Wargovich, Michael J.</creator><creatorcontrib>Hatono, Shunso ; Jimenez, Arnie ; Wargovich, Michael J.</creatorcontrib><description>Sulfur-containing substances derived from garlic and onion have been shown to prevent experimental carcinogenesis. One of the hypotheses explaining the mechanisms of the chemopreventive activity of these substances is that they activate detoxification systems such as glutathione S-trans-ferase (GST). In this study the effects of S-allylcysteine (SAC), a water-soluble organosulfur compound derived from garlic, on GST activities in the liver, small intestine and colon were investigated. Additionally, we examined SAC for chemopreventive effects on aberrant crypt foci, which are the most likely precursors of colon cancers. In the rat colonic aberrant crypt assay administration of SAC during the initiation period decreased the number of aberrant crypt foci by 33 and 54% in groups given 40 or 80% maximum tolerated dose (MTD) of SAC respectively. The number of aberrant crypt foci, however, was not changed when SAC was given during the promotion period. GST activity in the liver was increased significantly by 41% 12 h after a single oral administration of 3.5 mmol/kg SAC and this elevated GST level was maintained over a 72 h period. GST levels were increased significantly by the administration of SAC (1.8 mmol/kg/ day for 3 days) not only in the liver but also in the proximal and middle small bowel. Isozyme levels of GST after administration of SAC were also determined using Western blotting. Hepatic GST-α and GST-μ were significantly increased by 35 and 42% respectively after oral administration of SAC. GST-π levels were lower than the detection limit (130 ng/mg/protein) in both the control and SAC-treated groups. These results strongly support the previous working hypothesis that SAC exhibits chemopreventive activity by exerting specific effects on carcinogen detoxification systems.</description><identifier>ISSN: 0143-3334</identifier><identifier>EISSN: 1460-2180</identifier><identifier>DOI: 10.1093/carcin/17.5.1041</identifier><identifier>PMID: 8640910</identifier><identifier>CODEN: CRNGDP</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>1,2-Dimethylhydrazine ; Allium sativum ; Animals ; Anticarcinogenic Agents - pharmacology ; Biological and medical sciences ; Carcinogenesis, carcinogens and anticarcinogens ; Carcinogens - metabolism ; Chemical agents ; Colon - enzymology ; Cysteine - analogs &amp; derivatives ; Cysteine - pharmacology ; Dimethylhydrazines - metabolism ; Dimethylhydrazines - toxicity ; Glutathione Transferase - physiology ; Inactivation, Metabolic ; Intestine, Small - enzymology ; Isoenzymes - physiology ; Liver - enzymology ; Male ; Medical sciences ; Rats ; Rats, Inbred F344 ; Tumors</subject><ispartof>Carcinogenesis (New York), 1996-05, Vol.17 (5), p.1041-1044</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-45a8a65844bc5394d2b0202294c37365d327be07916c1c92c1748cec51e4f2903</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27928,27929</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3084354$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8640910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hatono, Shunso</creatorcontrib><creatorcontrib>Jimenez, Arnie</creatorcontrib><creatorcontrib>Wargovich, Michael J.</creatorcontrib><title>Chemopreventive effect of S-allylcysteine and its relationship to the detoxification enzyme glutathione S-transferase</title><title>Carcinogenesis (New York)</title><addtitle>Carcinogenesis</addtitle><description>Sulfur-containing substances derived from garlic and onion have been shown to prevent experimental carcinogenesis. One of the hypotheses explaining the mechanisms of the chemopreventive activity of these substances is that they activate detoxification systems such as glutathione S-trans-ferase (GST). In this study the effects of S-allylcysteine (SAC), a water-soluble organosulfur compound derived from garlic, on GST activities in the liver, small intestine and colon were investigated. Additionally, we examined SAC for chemopreventive effects on aberrant crypt foci, which are the most likely precursors of colon cancers. In the rat colonic aberrant crypt assay administration of SAC during the initiation period decreased the number of aberrant crypt foci by 33 and 54% in groups given 40 or 80% maximum tolerated dose (MTD) of SAC respectively. The number of aberrant crypt foci, however, was not changed when SAC was given during the promotion period. GST activity in the liver was increased significantly by 41% 12 h after a single oral administration of 3.5 mmol/kg SAC and this elevated GST level was maintained over a 72 h period. GST levels were increased significantly by the administration of SAC (1.8 mmol/kg/ day for 3 days) not only in the liver but also in the proximal and middle small bowel. Isozyme levels of GST after administration of SAC were also determined using Western blotting. Hepatic GST-α and GST-μ were significantly increased by 35 and 42% respectively after oral administration of SAC. GST-π levels were lower than the detection limit (130 ng/mg/protein) in both the control and SAC-treated groups. These results strongly support the previous working hypothesis that SAC exhibits chemopreventive activity by exerting specific effects on carcinogen detoxification systems.</description><subject>1,2-Dimethylhydrazine</subject><subject>Allium sativum</subject><subject>Animals</subject><subject>Anticarcinogenic Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Carcinogens - metabolism</subject><subject>Chemical agents</subject><subject>Colon - enzymology</subject><subject>Cysteine - analogs &amp; derivatives</subject><subject>Cysteine - pharmacology</subject><subject>Dimethylhydrazines - metabolism</subject><subject>Dimethylhydrazines - toxicity</subject><subject>Glutathione Transferase - physiology</subject><subject>Inactivation, Metabolic</subject><subject>Intestine, Small - enzymology</subject><subject>Isoenzymes - physiology</subject><subject>Liver - enzymology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Tumors</subject><issn>0143-3334</issn><issn>1460-2180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kM1v1DAQxS1EVZaWOxckHxC3tJ7YzscRbSlFqkRVKCAulncyZg1OsthO1eWvJ-2u9jTSe2_eaH6MvQZxBqKV52gj-uEc6jM9CwqesQWoShQlNOI5WwhQspBSqhfsZUq_hYBK6vaYHTeVEi2IBZuWa-rHTaR7GrK_J07OEWY-Ov6lsCFsA25TJj8Qt0PHfU48UrDZj0Na-w3PI89r4h3l8cE7j08Op-Hftif-K0zZ5vWs0NyWox2So2gTnbIjZ0OiV_t5wu4uP3xdXhXXnz9-Wr6_LlBJlQulbWMr3Si1Qi1b1ZUrUYqybBXKWla6k2W9IlG3UCFgWyLUqkFCDaRc2Qp5wt7tejdx_DtRyqb3CSkEO9A4JQO6ktBoNQfFLohxTCmSM5voexu3BoR5JG12pA3URptH0vPKm333tOqpOyzs0c7-271vE9rg5u_Rp0NMikbJp8vFLuZnzA8H28Y_pqplrc3Vj5_mBi6-fV_eXpob-R8CvJiW</recordid><startdate>19960501</startdate><enddate>19960501</enddate><creator>Hatono, Shunso</creator><creator>Jimenez, Arnie</creator><creator>Wargovich, Michael J.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>19960501</creationdate><title>Chemopreventive effect of S-allylcysteine and its relationship to the detoxification enzyme glutathione S-transferase</title><author>Hatono, Shunso ; Jimenez, Arnie ; Wargovich, Michael J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-45a8a65844bc5394d2b0202294c37365d327be07916c1c92c1748cec51e4f2903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>1,2-Dimethylhydrazine</topic><topic>Allium sativum</topic><topic>Animals</topic><topic>Anticarcinogenic Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Carcinogens - metabolism</topic><topic>Chemical agents</topic><topic>Colon - enzymology</topic><topic>Cysteine - analogs &amp; derivatives</topic><topic>Cysteine - pharmacology</topic><topic>Dimethylhydrazines - metabolism</topic><topic>Dimethylhydrazines - toxicity</topic><topic>Glutathione Transferase - physiology</topic><topic>Inactivation, Metabolic</topic><topic>Intestine, Small - enzymology</topic><topic>Isoenzymes - physiology</topic><topic>Liver - enzymology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hatono, Shunso</creatorcontrib><creatorcontrib>Jimenez, Arnie</creatorcontrib><creatorcontrib>Wargovich, Michael J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Carcinogenesis (New York)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hatono, Shunso</au><au>Jimenez, Arnie</au><au>Wargovich, Michael J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemopreventive effect of S-allylcysteine and its relationship to the detoxification enzyme glutathione S-transferase</atitle><jtitle>Carcinogenesis (New York)</jtitle><addtitle>Carcinogenesis</addtitle><date>1996-05-01</date><risdate>1996</risdate><volume>17</volume><issue>5</issue><spage>1041</spage><epage>1044</epage><pages>1041-1044</pages><issn>0143-3334</issn><eissn>1460-2180</eissn><coden>CRNGDP</coden><abstract>Sulfur-containing substances derived from garlic and onion have been shown to prevent experimental carcinogenesis. One of the hypotheses explaining the mechanisms of the chemopreventive activity of these substances is that they activate detoxification systems such as glutathione S-trans-ferase (GST). In this study the effects of S-allylcysteine (SAC), a water-soluble organosulfur compound derived from garlic, on GST activities in the liver, small intestine and colon were investigated. Additionally, we examined SAC for chemopreventive effects on aberrant crypt foci, which are the most likely precursors of colon cancers. In the rat colonic aberrant crypt assay administration of SAC during the initiation period decreased the number of aberrant crypt foci by 33 and 54% in groups given 40 or 80% maximum tolerated dose (MTD) of SAC respectively. The number of aberrant crypt foci, however, was not changed when SAC was given during the promotion period. GST activity in the liver was increased significantly by 41% 12 h after a single oral administration of 3.5 mmol/kg SAC and this elevated GST level was maintained over a 72 h period. GST levels were increased significantly by the administration of SAC (1.8 mmol/kg/ day for 3 days) not only in the liver but also in the proximal and middle small bowel. Isozyme levels of GST after administration of SAC were also determined using Western blotting. Hepatic GST-α and GST-μ were significantly increased by 35 and 42% respectively after oral administration of SAC. GST-π levels were lower than the detection limit (130 ng/mg/protein) in both the control and SAC-treated groups. These results strongly support the previous working hypothesis that SAC exhibits chemopreventive activity by exerting specific effects on carcinogen detoxification systems.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>8640910</pmid><doi>10.1093/carcin/17.5.1041</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0143-3334
ispartof Carcinogenesis (New York), 1996-05, Vol.17 (5), p.1041-1044
issn 0143-3334
1460-2180
language eng
recordid cdi_proquest_miscellaneous_15631854
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects 1,2-Dimethylhydrazine
Allium sativum
Animals
Anticarcinogenic Agents - pharmacology
Biological and medical sciences
Carcinogenesis, carcinogens and anticarcinogens
Carcinogens - metabolism
Chemical agents
Colon - enzymology
Cysteine - analogs & derivatives
Cysteine - pharmacology
Dimethylhydrazines - metabolism
Dimethylhydrazines - toxicity
Glutathione Transferase - physiology
Inactivation, Metabolic
Intestine, Small - enzymology
Isoenzymes - physiology
Liver - enzymology
Male
Medical sciences
Rats
Rats, Inbred F344
Tumors
title Chemopreventive effect of S-allylcysteine and its relationship to the detoxification enzyme glutathione S-transferase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T02%3A05%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemopreventive%20effect%20of%20S-allylcysteine%20and%20its%20relationship%20to%20the%20detoxification%20enzyme%20glutathione%20S-transferase&rft.jtitle=Carcinogenesis%20(New%20York)&rft.au=Hatono,%20Shunso&rft.date=1996-05-01&rft.volume=17&rft.issue=5&rft.spage=1041&rft.epage=1044&rft.pages=1041-1044&rft.issn=0143-3334&rft.eissn=1460-2180&rft.coden=CRNGDP&rft_id=info:doi/10.1093/carcin/17.5.1041&rft_dat=%3Cproquest_cross%3E15631854%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15631854&rft_id=info:pmid/8640910&rfr_iscdi=true